Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 1
2006 1
2007 3
2008 3
2009 1
2010 1
2011 4
2012 4
2013 5
2014 5
2015 1
2016 3
2017 1
2018 5
2019 4
2020 10
2021 11
2022 6
2023 1
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

65 results

Results by year

Filters applied: . Clear all
Page 1
Germline loss-of-function SAMD9 and SAMD9L alterations in adult myelodysplastic syndromes.
Nagata Y, Narumi S, Guan Y, Przychodzen BP, Hirsch CM, Makishima H, Shima H, Aly M, Pastor V, Kuzmanovic T, Radivoyevitch T, Adema V, Awada H, Yoshida K, Li S, Sole F, Hanna R, Jha BK, LaFramboise T, Ogawa S, Sekeres MA, Wlodarski MW, Cammenga J, Maciejewski JP. Nagata Y, et al. Among authors: jha bk. Blood. 2018 Nov 22;132(21):2309-2313. doi: 10.1182/blood-2017-05-787390. Epub 2018 Oct 15. Blood. 2018. PMID: 30322869 Free PMC article. No abstract available.
TET2 mutations and clonal dynamics.
Kishtagari A, Jha BK, Maciejewski JP. Kishtagari A, et al. Among authors: jha bk. Oncotarget. 2019 Mar 12;10(21):2010-2011. doi: 10.18632/oncotarget.26779. eCollection 2019 Mar 12. Oncotarget. 2019. PMID: 31007843 Free PMC article. No abstract available.
Multiple Myeloma Therapy: Emerging Trends and Challenges.
Dima D, Jiang D, Singh DJ, Hasipek M, Shah HS, Ullah F, Khouri J, Maciejewski JP, Jha BK. Dima D, et al. Among authors: jha bk. Cancers (Basel). 2022 Aug 23;14(17):4082. doi: 10.3390/cancers14174082. Cancers (Basel). 2022. PMID: 36077618 Free PMC article. Review.
Genomics of therapy-related myeloid neoplasms.
Kuzmanovic T, Patel BJ, Sanikommu SR, Nagata Y, Awada H, Kerr CM, Przychodzen BP, Jha BK, Hiwase D, Singhal D, Advani AS, Nazha A, Gerds AT, Carraway HE, Sekeres MA, Mukherjee S, Maciejewski JP, Radivoyevitch T. Kuzmanovic T, et al. Among authors: jha bk. Haematologica. 2020 Mar;105(3):e98-e101. doi: 10.3324/haematol.2019.219352. Epub 2019 Aug 14. Haematologica. 2020. PMID: 31413096 Free PMC article. No abstract available.
TET2 mutation as prototypic clonal hematopoiesis lesion.
Guarnera L, Jha BK. Guarnera L, et al. Among authors: jha bk. Semin Hematol. 2024 Feb;61(1):51-60. doi: 10.1053/j.seminhematol.2024.01.013. Epub 2024 Feb 2. Semin Hematol. 2024. PMID: 38431463 Review.
Rare germline alterations of myeloperoxidase predispose to myeloid neoplasms.
Kongkiatkamon S, Terkawi L, Guan Y, Adema V, Hasipek M, Dombrovski T, Co M, Walter W, Awada H, Parker Y, Hutter S, Pagliuca S, Gurnari C, Rogers HJ, Meggendorfer M, Lindner DJ, Haferlach T, Visconte V, LaFramboise T, Jha BK, Maciejewski JP. Kongkiatkamon S, et al. Among authors: jha bk. Leukemia. 2022 Aug;36(8):2086-2096. doi: 10.1038/s41375-022-01630-0. Epub 2022 Jun 27. Leukemia. 2022. PMID: 35761024
Molecular and clinical analyses of PHF6 mutant myeloid neoplasia provide their pathogenesis and therapeutic targeting.
Kubota Y, Gu X, Terkawi L, Bodo J, Przychodzen BP, Awada H, Williams N, Gurnari C, Kawashima N, Aly M, Durmaz A, Mori M, Ponvilawan B, Kewan T, Bahaj W, Meggendorfer M, Jha BK, Visconte V, Rogers HJ, Haferlach T, Maciejewski JP. Kubota Y, et al. Among authors: jha bk. Nat Commun. 2024 Feb 28;15(1):1832. doi: 10.1038/s41467-024-46134-w. Nat Commun. 2024. PMID: 38418452 Free PMC article.
65 results